Skip to main content
. 2021 Jan 14;11:1345. doi: 10.1038/s41598-020-79750-9

Table 1.

Characteristics of recruited subjects in this study.

Variable Healthy subjects (n = 42) Patients with ovarian endometriomas (n = 45) p value
Age (in years)
Mean ± S.D 33.6 ± 7.6 33.0 ± 6.6 0.99
Median (range) 32(23–49) 32(22–48)
Menstrual phase
Proliferative ND 22 (48.9%) NA
Secretory 23 (51.1%)
Parity
0 20 (47.6%) 23 (51.1%) 0.71
1 18 (42.9%) 20 (44.4%)
 ≥ 2 4 (9.5%) 2 (4.4%)
rASRM score
Mean ± S.D NA 38.8 ± 16.97 NA
Median (range) 48(4–76)
rASRM stage
I NA 1 (2.2%) NA
II 0 (0.0%)
III 24 (53.3%)
IV 20 (44.4%)
Severity of dysmenorrhea
None 35(83.3%) 19 (43.2%) 0.0003
Mild 4 (9.5%) 19 (43.2%)
Moderate 3 (7.1%) 6 (13.3%)
Severe 0 (0.0%) 1 (2.2%)
Co-occurrence with uterine fibroids
No 36 (85.7%) 34 (75.6%) 0.29
Yes 6 (14.3%) 11 (24.4%)
Co-occurrence with adenomyosis
No 42 (100.0%) 39 (86.7%) 0.056
Yes 0 (0.0%) 6 (13.3%)
Co-occurrence with deep endometriosis
No 42 (100.0%) 43 (95.6%) 0.49
Yes 0 (0.0%) 2 (4.4%)

rASRM revised American Society for Reproductive Medicine classification system for endometriosis, ND not determined, NA not applicable.